By Topic

FDA Regulation of Implantable Sensors: Demonstrating Safety and Effectiveness for Marketing in the U.S.

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Smith, J.J. ; Hogan & Hartson LLP, Washington ; Henderson, J.A.

Implantable sensors are gaining considerable attention in the research and medical communities due to their potential to enhance the detection and monitoring of medical conditions such as cancer, diabetes, and heart disease. The use of implantable sensors for these exciting applications bring them under the regulatory oversight of the United States Food and Drug Administration (FDA). As medical devices intended for long-term implantation that inherently involve some risk, the FDA will carefully evaluate these products prior to allowing them to enter the U.S. market. This paper provides a brief overview of the FDA medical device regulatory framework under which implantable sensors for medical purposes are regulated. It also addresses particular concerns the FDA may raise with respect to these products including, potential sensor breakage and migration in vivo, biocompatibility, electromagnetic compatibility, electromagnetic interference, wireless telemetry, risk/benefit, and clinical utility.

Published in:

Sensors Journal, IEEE  (Volume:8 ,  Issue: 1 )